Which medicine works best for Covid-19 treatment? WHO answers

Very few children have become critically ill with Covid-19, but severe symptoms like chest pains can occur.

Picture: Pixabay

Last Updated on January 19, 2022 by The Health Master

Healthcare experts around the world tout vaccinations and adherence to Covid-appropriate behavior as being paramount to the fight against the coronavirus.

For those infected, it is equally important to know your best treatment options — the right medicines and drugs that have been effective in reducing mortality, hospitalization, and ventilation.

As per the World Health Organization (WHO), the following drugs can be used for COVID-19 treatment:

  • Baricitinib
  • Ruxolitinib,
  • Tofacitinib,
  • Sotrovimab,
  • Casirivimab-imdevimab,
  • Tocilizumab,
  • Sarilumab.

While baricitinib, tocilizumab, or sarilumab are highly recommended for treatment, roxolitinib, tofacitinib, sotrovimab, and casirivimab-imdevimab are usually given either as a substitute or only under certain circumstances.

Meanwhile, the use of following medicines are not currently recommended due to a lack of proof for their usage being beneficial or the medicines still being under clinical trials:

  • Ivermectin,
  • Hydroxychloroquine,
  • Lopinavir/ritonavir,
  • Remdesivir .

So far, the use of casirivimab and imdevimab for children has been recommended, as per the WHO. Tocilizumab is also recommended for kids.

Very few children have become critically ill with Covid-19, but severe symptoms like chest pains can occur.

However, as previously mentioned, vaccination still remains our best weapon against the coronavirus.

“Vaccination is having a substantial impact on case numbers and hospitalizations in a number of high-income countries, but limitations in global access to vaccines mean that many populations remain vulnerable,” the WHO says.

Govt notifies New Drugs and Clinical Trials (Amendment) Rules 2022

Drug recall: Sun Pharma, Lupin recall these drugs

FDA starts collecting Antigen Home Testing Kits data

USFDA approves drug for the treatment of Eczema

USFDA gives warning letter to Aurobindo Pharma for API facility

Kerala DCA writes to NPPA to bring Kidney drug under DPCO

Pharma firms to install PNG run boilers to improve Air quality

BIS notifies new standard for these Medical Devices

Latest Notifications: Medical Devices

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
YouTube Icon

Enter your email address:

Delivered by FeedBurner